Generics Maker Can't Duck Baxter Suit Over Brevibloc
Generics maker HQ Specialty Pharma Corp. must face Baxter Healthcare Corp.'s infringement suit over the generic version of the anti-arrhythmia drug Brevibloc after a New Jersey federal judge refused to toss...To view the full article, register now.
Already a subscriber? Click here to view full article